Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

SHIRE PLC: Full Year 2012 Results Date Notification


Full Year 2012 results date notification - February 14, 2013

Dublin, Ireland - February 1, 2013 - Shire plc (LSE: SHP, NASDAQ: SHPG), will announce full year 2012 earnings on Thursday February 14, 2012.

Results press release will be 12:00 GMT / 07:00 EST issued at:

Investor conference call time: 14:00 GMT / 09:00 EST

Live conference call for investors:

Angus Russell, Chief Executive Officer and Graham Hetherington, Chief Financial Officer will host the investor and analyst conference call at 14:00 GMT/9:00 EST.

The details of the conference call are as follows:

UK dial in: 08082370030 or 02031394830

US dial in: 1 866 928 7517 or 1 718 873 9077

International Access http://wpc.1726.planetstream.net/001726/FEL_Events_International_Access_List.pdf

Numbers:

Password/Conf ID: 99054603#

Live Webcast: http://event.onlineseminarsolutions.com/r.htm?e=580771&s=1&k=FB534593ACC4ADF8B78 2C460E7624D98

Replay:

A replay of the presentation will be available for two weeks by phone and by webcast for three months. Details can be found on our Investor Relations website http://www.shire.com/shireplc/en/investors.

For further information please contact:

Investor Relations Souheil Salah (ssalah@shire.com) +44 1256 894 160


                    Erin K. Kelly (erikelly@shire.com)       +1 781 482 9541   

Notes to editors

Shire enables people with life-altering conditions to lead better lives.

Through our deep understanding of patients' needs, we develop and provide
healthcare in the areas of:

  * Behavioral Health and Gastro Intestinal conditions
      * Rare Diseases
      * Regenerative Medicine
    as well as other symptomatic conditions treated by specialist physicians.

We aspire to imagine and lead the future of healthcare, creating value for
patients, physicians, policymakers, payors and our shareholders.

For further information on Shire, please visit the Company's website: 
www.shire.com.
                                                                              2

Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX

Press Release                                   

www.shire.com

END

-0- Feb/01/2013 14:00 GMT

Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement